Clinical trial Recruiting at 1 site Interventional Ages 30 to 50 Women only

Comparing glue embolization and conservative treatment for pelvic congestion syndrome

Official title: Glue Embolization Versus Conservative Treatment for Pelvic Congestion Syndrome: A Randomized Trial

Run by Tanta University · NCT06560294 · Data updated 2026-11-12

This study is testing whether a new glue treatment works better than standard care for women aged 30 to 50 with pelvic congestion syndrome to help relieve their chronic pelvic pain.

Quick facts

Study typeInterventional
Ages30 Years to 50 Years
SexWomen only
Enrollment40 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, ElGharbia)
StatusRecruiting
StartedAugust 17, 2024
Main results expectedOctober 1, 2025
Study endsOctober 1, 2025
Registry record updatedAugust 19, 2025
Trial IDNCT06560294 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 30 to 50 who are experiencing symptoms of pelvic congestion syndrome.

Probably not a fit

Patients who are pregnant, breastfeeding, or have alternative causes of chronic pelvic pain may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the safety and efficacy of glue embolization compared to conservative treatment methods for pelvic congestion syndrome (PCS), a condition that causes chronic pelvic pain in women. The study will involve women aged 30 to 50 who experience symptoms of PCS. Participants will receive either the micronized purified flavonoid fraction (Daflon) or undergo glue embolization to occlude incompetent pelvic veins. The outcomes will be assessed to determine which treatment provides better relief from symptoms.

Why it matters

Potential benefit: If successful, this study could provide a more effective treatment option for women suffering from pelvic congestion syndrome.

How similar studies have gone: While traditional conservative treatments have been used for PCS, the approach of glue embolization is relatively novel and has not been extensively tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women aged from 30 to 50 years.
* Complaining from pelvic congestion syndrome.

Exclusion Criteria:

* Pregnant women at any gestational age, women who gave birth less than 12 months ago, and breastfeeding mothers.
* Patients who are treated with opiates to reduce pelvic pain in the period before the study.
* Patient with history of contrast allergy
* Patient with renal impairment
* Patient has alternative gynecological cause of chronic pelvic pain as pelvic inflammatory disease (PID), endometriosis, fibroid, adenomyosis, ovarian cyst
* Patient underwent any previous intervention for pelvic congestion syndrome as laparoscopy or surgery.

Where it's running

  • Tanta University
    Tanta, ElGharbia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.